|
**Overview**: Andrology Panel**Introduction**: The Andrology Panel is a diagnostic tool designed to screen for male hormonal disorders using serum samples. In India, male hypogonadism and infertility affect a significant number of men (testosterone deficiency ~10-20 percent in aging males, infertility contributing to 40-50 percent of couple issues), with causes including hypogonadotropic hypogonadism, varicocele, obesity, diabetes, and stress. High morbidity from underdiagnosis in rural areas, cultural stigma around male infertility, limited andrology access, and delayed treatment leading to reduced quality of life or family stress. Per endocrinology and biochemistry practices aligned with ICMR guidelines, the test employs immunoassay for detailed hormone analysis over 1-2 days with high sensitivity/specificity, valuable for initial evaluation in men with low libido, erectile dysfunction, or infertility. This diagnostic falls under hormone screening and targets men with suspected hormonal disorders, addressing accurate detection to guide testosterone replacement or fertility management. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling precise identification, facilitating treatment, and reducing infertility burden. Its serum-based approach ensures reliable performance in India's diverse lab settings.**Other Names**: Andrology Pnl.**FDA Status**: FDA approved, CLIA certified for endocrinology/biochemistry, compliant with 2025 standards.**Historical Milestone**: Expanded with hormone panels; in India, prominence with rising male infertility awareness.**Purpose**: The test screens for 4 parameters including total testosterone to guide male hormonal assessment, evaluate gonadal function, inform treatment.**Test Parameters**: 1. Total Testosterone, 2. Free Testosterone, 3. LH, 4. FSH.**Pretest Condition**: Fasting 10-12 hours recommended; patients should report low libido, erectile dysfunction, infertility, or fatigue.**Specimen**: 3 mL serum in 1 SST, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 8 hours with proper handling to preserve analyte integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.**Medical History**: Patients should provide details on sexual function, fertility history, fatigue, obesity, diabetes, medications, or family endocrine disorders.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of untreated hormonal disorders including infertility or osteoporosis, benefits of early detection, and minimal discomfort from venipuncture.**Procedural Considerations**: The test involves sample processing using immunoassay by trained personnel to ensure sterile technique, avoid hemolysis, and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols, and store kits according to manufacturer specifications to ensure reliability.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, hemolysis, or recent stress/medications can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Abnormal results indicate possible male hormonal disorder, necessitating further investigation like specialist consultation or additional testing. Normal results may require follow-up if symptoms persist.**Specialist Consultation**: Andrologists or endocrinologists should be consulted for case management, treatment planning, and coordination with men's health programs.**Additional Supporting Tests**: Semen analysis, scrotal ultrasound for confirmation.**Test Limitations**: The test may miss non-hormonal causes or require morning sampling; comprehensive approach with clinical correlation required.**References**: Indian Journal of Endocrinology 2024, Male Infertility Studies India 2023. |
